
CADL
Healthcare · Biotechnology · $486.4M market cap
$6.20-2.19 (-26.1%)Nov 13, 4:27 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +6.2% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.30 | -0.28 | +6.7% |
| Aug 13, 2026 | Before the open | -0.22 | -0.35 | -59.1% |
| May 14, 2026 | Before the open | -0.33 | -0.14 | +57.6% |
| Mar 26, 2026 | Time not confirmed | -0.25 | -0.29 | -17.0% |
| Nov 13, 2025 | Before the open | -0.16 | -0.23 | -43.8% |
| Aug 14, 2025 | Before the open | -0.17 | -0.20 | -17.6% |
| May 13, 2025 | Before the open | -0.24 | -0.14 | +41.7% |
| Mar 13, 2025 | Time not confirmed | -0.30 | -0.40 | -33.3% |
| Nov 14, 2024 | Time not confirmed | — | -0.33 | — |
| Aug 13, 2024 | Time not confirmed | — | -0.74 | — |
| May 14, 2024 | Before the open | -0.28 | -0.28 | -0.6% |
| Mar 28, 2024 | Before the open | -0.16 | -0.38 | -137.5% |
| Nov 9, 2023 | Before the open | -0.19 |
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent…
| -0.29 |
| -52.6% |
| Aug 10, 2023 | Before the open | -0.37 | -0.33 | +10.8% |
| May 11, 2023 | Before the open | -0.35 | -0.30 | +14.3% |
| Mar 30, 2023 | Before the open | -0.31 | -0.18 | +41.9% |
| Nov 10, 2022 | Before the open | -0.36 | -0.31 | +13.9% |
| Aug 5, 2022 | Before the open | -0.43 | -0.32 | +25.6% |
| May 12, 2022 | Before the open | -0.31 | -0.32 | -3.2% |
| Mar 29, 2022 | Before the open | -0.32 | 0.31 | +196.9% |
| Nov 12, 2021 | Before the open | -0.29 | -0.34 | -17.2% |
| Sep 8, 2021 | Before the open | -0.12 | -0.31 | -158.3% |
| Jun 2, 2021 | Time not confirmed | -0.35 | -0.35 | +0.7% |